Researchers show the potential of their digital health platform to help treat acute lymphoblastic leukemia by being able to personalize drug dosages and combinations.
'Turbocharged artificial intelligence' could personalize combination therapy in pediatric leukemia
Science Daily - 13 Dec 2016 14:45
Researchers show the potential of their digital health platform to help treat acute lymphoblastic leukemia by being able to personalize drug dosages and combinations.
Share this Article
Recommended